In cancer, INPP4A and INPP4B are considered to act as tumor suppressors by inhibiting the PI3K/AKT signaling pathway in several tumor types including breast, ovary, lung, pancreatic, melanoma, and esophageal cancer (40, 42, 43). Here, PIK3CA is linked to esophageal cancer.